Wave Life Sciences
92 hedge funds and large institutions have $1.03B invested in Wave Life Sciences in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 33 reducing their positions, and 16 closing their positions.
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
1.62% more ownership
Funds ownership: 81.18% → 82.8% (+1.6%)
0% more funds holding
Funds holding: 92 → 92 (0)
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
3% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 33
14% less capital invested
Capital invested by funds: $1.19B → $1.03B (-$165M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10.1M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.41M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$5.53M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$7.76M |
| 2 |
BM
Bridger Management
New York
|
-$4.65M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.38M |
| 4 |
Millennium Management
New York
|
-$3.21M |
| 5 |
JP Morgan Chase
New York
|
-$1.83M |
WVE Hedge Fund Activity: Q4 2018 in Review
92 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2018, worth a combined $1.03B — down 14% from $1.19B a quarter earlier.
Fund positioning in WVE was balanced in Q4 2018: 16 funds opened new positions, 16 closed out, 32 added to existing stakes and 33 trimmed.
The largest buyer was BlackRock, adding an estimated $15M. The largest seller was Perceptive Advisors, cutting an estimated $7.76M.
- 92 institutional investors held Wave Life Sciences (WVE) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $1.03B of Wave Life Sciences stock for Q4 2018, down 14% quarter-over-quarter.
- 16 funds opened new Wave Life Sciences positions in Q4 2018 and 16 closed out, a net change of 0 holders.
- The largest Wave Life Sciences buyer in Q4 2018 was BlackRock, an estimated $15M added.
- The largest Wave Life Sciences seller in Q4 2018 was Perceptive Advisors, an estimated $7.76M sold.
Based on aggregated 13F filings for Q4 2018.